Biogen Idec (NASDAQ:BIIB)

Top Analyst Upgrades and Downgrades: ADT, Altria, Biogen, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku, Schwab, Wells Fargo and More

Posted: December 2, 2019 at 9:05 am

Stocks were indicated to open marginally higher on Monday after a shortened Thanksgiving week in the United States. The major equity indexes set all-time highs again last week. Investors are ...
Read Full Story »

Major Biopharma Catalysts on the December FDA Calendar

Posted: November 29, 2019 at 10:40 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Short Sellers Run For Cover From Major Biotechs

Posted: November 27, 2019 at 8:40 am

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

Posted: November 12, 2019 at 10:00 am

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Posted: November 12, 2019 at 9:15 am

Stocks were mixed in the premarket on Tuesday and the day was just looking for direction after last week's all-time highs. Investors still have a lot of pressing issues and ...
Read Full Story »

Multiple Sclerosis Treatment Wins Big FDA Approval

Posted: October 30, 2019 at 1:05 pm

Biogen Inc. (NASDAQ: BIIB) and Alkermes PLC (NASDAQ: ALKS) announced an update from the U.S. Food and Drug Administration on Wednesday morning. The FDA approved Vumerity for the treatment of ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

Posted: October 25, 2019 at 10:05 am

The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analysts Upgrades and Downgrades: Biogen, Coke, Crowdstrike, Kohl’s, ServiceNow, Snap, Travelers and More

Posted: October 23, 2019 at 9:45 am

The futures traded flat Wednesday morning as third-quarter earnings continue to pour in. If things were simple enough, it might feel like all that persistent uncertainty around trade wars, impeachment, ...
Read Full Story »

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Posted: October 22, 2019 at 10:20 am

Biogen Inc. (NASDAQ: BIIB) released its third-quarter financial results before the markets opened on Tuesday. The biotech giant posted $9.17 in earnings per share (EPS) and $3.60 billion in revenue. ...
Read Full Story »

How Biotech and Big Pharma Have Upside Heading Into Earnings

Posted: October 19, 2019 at 6:45 am

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Posted: October 18, 2019 at 9:00 am

Stocks were indicated to open marginally higher on Friday as earnings season is so far proving to be not as bad as many investors had modeled in for the third ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Posted: October 17, 2019 at 9:15 am
Last updated: October 18, 2019 8:16 am

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

Posted: October 10, 2019 at 10:00 am

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

Posted: September 25, 2019 at 9:30 am

The short interest data are out for the most recent settlement date, September 13. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

Posted: September 12, 2019 at 8:40 am

The short interest data are out for the most recent settlement date, August 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »